- Home
- RAMP vs TNDM Comparison
RAMP vs TNDM Comparison
Compare RAMP & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAMP
- TNDM
- Stock Information
- Founded
- RAMP 2018
- TNDM 2006
- Country
- RAMP United States
- TNDM United States
- Employees
- RAMP N/A
- TNDM N/A
- Industry
- RAMP EDP Services
- TNDM Medical/Dental Instruments
- Sector
- RAMP Technology
- TNDM Health Care
- Exchange
- RAMP Nasdaq
- TNDM Nasdaq
- Market Cap
- RAMP 2.2B
- TNDM 1.9B
- IPO Year
- RAMP 1987
- TNDM 2013
- Fundamental
- Price
- RAMP $26.34
- TNDM $17.89
- Analyst Decision
- RAMP Buy
- TNDM Buy
- Analyst Count
- RAMP 6
- TNDM 15
- Target Price
- RAMP $39.83
- TNDM $46.07
- AVG Volume (30 Days)
- RAMP 595.4K
- TNDM 2.4M
- Earning Date
- RAMP 02-05-2025
- TNDM 05-01-2025
- Dividend Yield
- RAMP N/A
- TNDM N/A
- EPS Growth
- RAMP N/A
- TNDM N/A
- EPS
- RAMP 0.00
- TNDM N/A
- Revenue
- RAMP $728,708,000.00
- TNDM $940,203,000.00
- Revenue This Year
- RAMP $14.77
- TNDM $8.70
- Revenue Next Year
- RAMP $8.08
- TNDM $11.06
- P/E Ratio
- RAMP $21,970.20
- TNDM N/A
- Revenue Growth
- RAMP 14.50
- TNDM 25.74
- 52 Week Low
- RAMP $21.45
- TNDM $17.64
- 52 Week High
- RAMP $38.00
- TNDM $53.69
- Technical
- Relative Strength Index (RSI)
- RAMP 27.48
- TNDM 18.56
- Support Level
- RAMP $24.97
- TNDM $17.64
- Resistance Level
- RAMP $29.77
- TNDM $19.51
- Average True Range (ATR)
- RAMP 1.14
- TNDM 1.59
- MACD
- RAMP -0.58
- TNDM -1.00
- Stochastic Oscillator
- RAMP 16.12
- TNDM 1.43
About RAMP LiveRamp Holdings Inc.
LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.